TrialThe Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis
Trial details
- Registry ID
- NCT04134091
- Phase
- Phase 2
LPCN
Lipocine Inc.
Company identity checked against sources
Browse linked trials and recorded changes, or follow this company for updates.
4Trials in this database
5Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
Completion dates · Pro
Which trial dates moved later?
Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features
Included trials
Check company identity source| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic SteatohepatitisNCT04134091 | LPCN | Phase 2 | Completed | 2021-06-24Actual |
| A Study of the Safety and Tolerability of LPCN 1144 in Subjects Who Completed the LPCN 1144-18-002 TrialNCT04685993 | LPCN | Phase 2 | Completed | 2022-03-01Actual |
| A Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and SarcopeniaNCT04874350 | LPCN | Phase 2 | Completed | 2023-12-18Actual |
| A Study to Assess the Safety and Efficacy of Oral LPCN 1154A in Women With Severe PPDNCT06979544 | LPCN | Phase 3 | Completed | 2026-01-16Actual |
A Study of the Safety and Tolerability of LPCN 1144 in Subjects Who Completed the LPCN 1144-18-002 Trial
Trial details
- Registry ID
- NCT04685993
- Phase
- Phase 2
A Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and Sarcopenia
Trial details
- Registry ID
- NCT04874350
- Phase
- Phase 2
A Study to Assess the Safety and Efficacy of Oral LPCN 1154A in Women With Severe PPD
Trial details
- Registry ID
- NCT06979544
- Phase
- Phase 3
Latest recorded trial changes
A Study to Assess the Safety and Efficacy of Oral LPCN 1154A in Women With Severe PPD
NCT06979544 · Lipocine Inc.
Participant count type changed
− Before
Estimated
+ After
Actual
Enrollment · participant count changed
− Before
80 participants (planned)
+ After
90 participants (actual)
Completion date type changed
− Before
Estimated
+ After
Actual
Primary completion date changed
− Before
Apr 2026
+ After
16 Jan 2026
Recruitment status changed
− Before
Recruiting
+ After
Completed